NCT01811394 2023-12-06
ISAC
Heidelberg University
Phase 2 Unknown
Clinical Trials
11 trialsNCT01586767 2023-09-21
Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
Massachusetts General Hospital
Phase NA Unknown
NCT02766686 2023-02-08
ProtoChoice-P
Technische Universität Dresden
Phase NA Unknown
NCT05692661 2023-01-20
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer
Shanghai Proton and Heavy Ion Center
Phase 1 Unknown
NCT05212857 2022-03-16
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Fudan University
Phase 2 Unknown
NCT05189067 2022-01-12
Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2/3 Unknown
NCT04717531 2021-06-04
Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT01494155 2021-02-02
Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Unknown
NCT04528394 2020-08-27
Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center
Phase 2 Unknown
NCT03006614 2017-01-16
PERS
Sun Yat-sen University
Phase 3 Unknown
NCT01182779 2010-08-17
HIT-1
Heidelberg University
Phase 3 Unknown